Characterization of Recombinant Wild Type and Site-Directed Mutations of Apolipoprotein C-III: Lipid Binding, Displacement of ApoE, and Inhibition of Lipoprotein Lipase-Reference-Cited by-同舟云学术

Characterization of Recombinant Wild Type and Site-Directed Mutations of Apolipoprotein C-III: Lipid Binding, Displacement of ApoE, and Inhibition of Lipoprotein Lipase

Published:2000-07-14 Issue:31 Volume:39 Page:9201-9212
ISSN:0006-2960
Container-title:Biochemistry
language:en
Short-container-title:Biochemistry

Author:

Liu Haiqun¹,Talmud Philippa J.¹,Lins Laurence¹,Brasseur Robert¹,Olivecrona Gunilla¹,Peelman Frank¹,Vandekerckhove Joël¹,Rosseneu Maryvonne¹,Labeur Christine¹

Affiliation:

1. Centre for Cardiovascular Genetics, Department of Medicine, Royal Free and University College, London Medical School, London, INSERM U410, Paris, France, Centre de Biologique Moléculaire Numérique, University of Gembloux, Belgium, Department of Medical Biosciences, Medical Biochemistry, Umeå University, Sweden, and Department of Biochemistry, Ghent University, Belgium

Publisher

American Chemical Society (ACS)

Subject

Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/bi0009441

Reference50 articles.

1. Variation at the apo AI/CIII/A1V gene complex is associated with elevated plasma levels of apo CIII

2. Epidemiology of triglycerides: A view from Framingham

3. Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men: The Caerphilly and Speedwell Collaborative Heart Disease Studies

4. Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease

5. Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors.

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia;Nature Reviews Cardiology;2022-03-22

2. Apolipoproteins in vascular biology and atherosclerotic disease;Nature Reviews Cardiology;2021-10-08

3. The Roles of ApoC-III on the Metabolism of Triglyceride-Rich Lipoproteins in Humans;Frontiers in Endocrinology;2020-07-28

4. Preparation of Lipid Nanodisks Containing Apolipoprotein E-Derived Synthetic Peptides for Biocompatible Delivery Vehicles Targeting Low-Density Lipoprotein Receptor;Biological and Pharmaceutical Bulletin;2019-08-01

5. Emerging Evidence that ApoC-III Inhibitors Provide Novel Options to Reduce the Residual CVD;Current Atherosclerosis Reports;2019-05-20